Compliance with inhaled asthma medication in preschool children

Gibson, N A; Ferguson, A E; Aitchison, T C; Paton, J Y
December 1995
Thorax;Dec1995, Vol. 50 Issue 12, p1274
Academic Journal
No abstract available.


Related Articles

  • Abstracts.  // Respiratory Care;Jul2009, Vol. 54 Issue 7, p826 

    The article presents abstracts on medical topics which include the undocumented patient information of asthma management in hospitalized adult patients, the use of inhaled corticosteroid in preschool children who are at risk for asthma, and the severity-dependent relationship of bronchiolitis...

  • Management of Wheezing in Preschool Children. Raissy, Hengameh H.; Blake, Kathryn // Pediatric Allergy, Immunology & Pulmonology;Sep2012, Vol. 25 Issue 3, p172 

    Diagnosis and management of asthma in preschool children are challenging. The Expert Panel Report 3 has recommendations for specific illness phenotypes to start long-term controller medication to reduce risk and impairment in children ages 0-4-year old. The use of daily-inhaled corticosteroids...

  • Once-Daily Inhaled Corticosteroids in Children with Asthma: Dry Powder Inhalers. Möller, C. // Drugs;Dec1999 Supplement 4, Vol. 58 Issue 6, p35 

    The cornerstone of pharmacological management of asthma in childhood is inhaled corticosteroids. These drugs are intended for long term treatment and, consequently, compliance is a major issue. Once-daily administration of maintenance medication would simplify treatment and it is likely that it...

  • Corticosteroids not a cure for asthma in toddlers. Chambers, Christopher V.; Russell, John J. // Patient Care;Jul2006, Vol. 40 Issue 7, p59 

    Presents an abstract of the study "Long-Term Inhaled Corticosteroids in Preschool Children at High Risk for Asthma," by T. W. Guilbert and colleagues, which appeared in the 2006 issue of the "New England Journal of Medicine."

  • A breath of fresh air: an example of asthma promotion in schools. Callens, Claire; Tibbins, Carly; Lenney, Warren // British Journal of School Nursing;Feb2011, Vol. 6 Issue 1, p35 

    The article offers the authors' insights on the Medicines for Children Research Network (MCRN) programme on education for asthma treatment. They said that the programme is made in partnership of Birmingham Medical Needs in School Services, and aims to involve children, youth, and families in...

  • Parental Preference for Short- Versus Long-Course Corticosteroid Therapy in Children With Asthma Presenting to the Pediatric Emergency Department. Williams, Kelli W.; Andrews, Annie L.; Heine, Daniel; Russell, W. Scott; Titus, M. Olivia // Clinical Pediatrics;Jan2013, Vol. 52 Issue 1, p30 

    Asthma is the most common chronic condition affecting children and a prominent chief complaint in pediatric emergency departments (ED). We aimed to determine parental preference between short- and long-term courses of oral corticosteroids for use in children with mild to moderate asthma...

  • Strategies to screen for adrenal suppression in children with asthma should take account of compliance with inhaled corticosteroids. Brodlie, Malcolm; McMurray, Ann; Crofton, Patricia M.; Bath, Louise; Cunningham, Steve // European Journal of Pediatrics;May2007, Vol. 166 Issue 5, p493 

    The article examines the prevalence of adrenal suppression (AS) in children attending a tertiary asthma clinic. It cites the importance of prescribing the lowest effective dose of inhaled corticosteroids (ICS) for children with asthma. It also states that compliance should be taken into account...

  • Mims UPDATE.  // GP: General Practitioner;2/4/2002, p80 

    Focuses on the use of Oxis Turbohaler, a medication used for asthma, in children by AstraZeneca company. Ingredient of the inhaler; Side-effects of the medicine; Dosage of the inhaler for children.

  • New Asthma Medication for Infants and Children. Preboth, Monica // American Family Physician;3/15/2001, Vol. 63 Issue 6, p1237 

    Reports on the approval of budesonide inhalation suspension, a new asthma medication, for infants and young children by the United States Food and Drug Administration. Description of budesonide inhalation suspension; How the medication should be administered.

  • The gap between evidence-based medicine and daily practice in the management of paediatric asthma. A pharmacy-based population study from The Netherlands. de Vries, Tjalling W.; Tobi, Hilde; Schirm, Eric; van den Berg, Paul; Duiverman, Eric J.; Jong-van den Berg, Lolkje T. W. // European Journal of Clinical Pharmacology;Jan2006, Vol. 62 Issue 1, p51 

    Objective: We evaluated the adherence to national guidelines for the treatment of asthma in childhood. Methods: Prescriptions for anti-asthma medication for children (0—14 years of age) were retrieved from the InterAction DataBase (IABD) for the year 2002. These were compared with...


Read the Article


Sign out of this library

Other Topics